Short answer · Medically reviewed summary · Last updated: 2026-04-07
Morquio syndrome is officially classified in medical literature as Mucopolysaccharidosis type IV (MPS IV), a term that reflects the underlying metabolic deficiency causing the condition. Common Synonyms and Historical Names While Morquio syndrome is the most widely recognized clinical name, it is frequently referred to as MPS IV in clinical settings. Historically, the condition was sometimes called Morquio-Brailsford syndrome, honoring the two physicians, Luis Morquio and James Brailsford, who independently described the skeletal features of the disorder in 1929.
Morquio syndrome is officially classified in medical literature as Mucopolysaccharidosis type IV (MPS IV), a term that reflects the underlying metabolic deficiency causing the condition.
While Morquio syndrome is the most widely recognized clinical name, it is frequently referred to as MPS IV in clinical settings. Historically, the condition was sometimes called Morquio-Brailsford syndrome, honoring the two physicians, Luis Morquio and James Brailsford, who independently described the skeletal features of the disorder in 1929. You may also encounter the name keratosulfaturia in older medical texts, which refers to the excessive excretion of keratan sulfate in the urine, a hallmark diagnostic marker of the disease.
The existence of multiple names for Morquio syndrome stems from the evolution of medical classification systems. As our understanding of lysosomal storage disorders deepened, clinicians moved away from eponyms (names based on the people who discovered them) toward biochemical classifications. MPS IV is now the preferred term because it accurately groups the condition with other mucopolysaccharidoses based on the specific enzyme deficiency involved. There are two distinct subtypes: Type A (caused by a deficiency in N-acetylgalactosamine-6-sulfatase) and Type B (caused by a deficiency in beta-galactosidase). In the International Classification of Diseases (ICD-10/11) and the OMIM database, you will primarily find the condition indexed under these systematic biochemical designations.
Today, medical professionals generally use Morquio syndrome when communicating with families to maintain historical continuity, but they will document it as MPS IV or MPS IVA/IVB in electronic health records to ensure precise diagnostic coding. Understanding these synonyms is vital for patients and caregivers when searching for clinical trials, support groups, or medical literature, as older databases may still use the eponymous Morquio-Brailsford syndrome terminology.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.